Aquestive Therapeutics, Inc. - 8-K Filing
Aquestive Therapeutics licensed exclusive U.S. rights for LIBERVANT to Eton Pharmaceuticals, receiving $10M upfront and up to $47.5M in milestones.
Tickers: $AQST
More Regulatory news
- Future Vision II Acquisition Corp. - 10-Q Filing
- THUNDER MOUNTAIN GOLD INC - 10-Q Filing
- MiNK Therapeutics, Inc. - 8-K Filing
- SusGlobal Energy Corp. - 10-Q Filing
- Ideal Power Inc. - 8-K Filing
- DIGI INTERNATIONAL INC - 8-K Filing
- ZeroStack Corp. - 8-K Filing
- Sound Point Meridian Capital, Inc. - 8-K Filing
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing